Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Rating of "Hold" from Analysts

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned a consensus recommendation of "Hold" from the eleven ratings firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $5.72.

A number of research firms have commented on DH. Stephens began coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an "equal weight" rating and a $5.00 target price for the company. Barclays reaffirmed an "underweight" rating and set a $4.00 target price on shares of Definitive Healthcare in a report on Monday, January 13th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th.

Definitive Healthcare Trading Down 1.1 %

DH stock traded down $0.06 during trading on Monday, hitting $5.19. The company had a trading volume of 1,341,948 shares, compared to its average volume of 786,633. The firm has a 50-day moving average price of $4.58 and a 200-day moving average price of $4.43. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The stock has a market cap of $599.55 million, a price-to-earnings ratio of -1.67, a PEG ratio of 4.24 and a beta of 1.45.

Insider Activity at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the business's stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares of the company's stock, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.84% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC raised its holdings in shares of Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock valued at $29,000 after purchasing an additional 6,794 shares during the period. Point72 DIFC Ltd raised its holdings in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock valued at $42,000 after purchasing an additional 8,215 shares during the period. Bayesian Capital Management LP bought a new stake in shares of Definitive Healthcare in the 4th quarter valued at about $41,000. Ieq Capital LLC bought a new stake in shares of Definitive Healthcare in the 4th quarter valued at about $51,000. Finally, Intech Investment Management LLC bought a new stake in shares of Definitive Healthcare in the 3rd quarter valued at about $55,000. 98.67% of the stock is owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.